Quantum-Si (QSI) Competitors $1.74 -0.03 (-1.69%) Closing price 04:00 PM EasternExtended Trading$1.74 0.00 (0.00%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QSI vs. EYPT, AEHR, ALNT, TRNS, LAB, CTKB, SENS, FEIM, MASS, and QTRXShould you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Allient (ALNT), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Frequency Electronics (FEIM), 908 Devices (MASS), and Quanterix (QTRX). These companies are all part of the "measuring and control equipment" industry. Quantum-Si vs. Its Competitors Eyepoint Pharmaceuticals Aehr Test Systems Allient Transcat Standard BioTools Cytek Biosciences Senseonics Frequency Electronics 908 Devices Quanterix Quantum-Si (NASDAQ:QSI) and Eyepoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends. Which has stronger valuation and earnings, QSI or EYPT? Quantum-Si has higher earnings, but lower revenue than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantum-Si$3.06M115.14-$101.01M-$0.68-2.56Eyepoint Pharmaceuticals$43.27M22.27-$130.87M-$2.68-5.22 Do analysts recommend QSI or EYPT? Quantum-Si presently has a consensus target price of $3.48, suggesting a potential upside of 99.71%. Eyepoint Pharmaceuticals has a consensus target price of $26.86, suggesting a potential upside of 92.11%. Given Quantum-Si's higher probable upside, equities analysts clearly believe Quantum-Si is more favorable than Eyepoint Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quantum-Si 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Eyepoint Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is QSI or EYPT more profitable? Eyepoint Pharmaceuticals has a net margin of -337.93% compared to Quantum-Si's net margin of -3,120.14%. Quantum-Si's return on equity of -44.57% beat Eyepoint Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Quantum-Si-3,120.14% -44.57% -39.45% Eyepoint Pharmaceuticals -337.93%-63.80%-50.72% Does the media refer more to QSI or EYPT? In the previous week, Quantum-Si and Quantum-Si both had 3 articles in the media. Eyepoint Pharmaceuticals' average media sentiment score of 0.81 beat Quantum-Si's score of 0.77 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum-Si 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Eyepoint Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, QSI or EYPT? Quantum-Si has a beta of 2.89, suggesting that its stock price is 189% more volatile than the S&P 500. Comparatively, Eyepoint Pharmaceuticals has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500. Do institutionals & insiders believe in QSI or EYPT? 39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. 30.0% of Quantum-Si shares are held by company insiders. Comparatively, 4.5% of Eyepoint Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryQuantum-Si beats Eyepoint Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Get Quantum-Si News Delivered to You Automatically Sign up to receive the latest news and ratings for QSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QSI vs. The Competition Export to ExcelMetricQuantum-SiELEC COMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$358.42M$46.71B$33.21B$10.65BDividend YieldN/A2.10%3.17%4.70%P/E Ratio-2.56736.22495.9727.65Price / Sales115.14423.851,680.87141.34Price / CashN/A103.0338.1662.20Price / Book1.356.777.776.79Net Income-$101.01M$551.26M$819.59M$275.88M7 Day Performance12.99%3.56%1.80%2.64%1 Month Performance51.30%37.85%9.31%9.13%1 Year Performance113.44%65.82%23,975.63%35.89% Quantum-Si Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QSIQuantum-Si2.4373 of 5 stars$1.74-1.7%$3.48+99.7%+111.4%$358.42M$3.06M-2.56150Analyst ForecastEYPTEyepoint Pharmaceuticals1.4978 of 5 stars$14.05+1.1%$26.86+91.2%+63.7%$968.47M$43.27M-5.24120News CoverageAnalyst ForecastAEHRAehr Test Systems1.6434 of 5 stars$30.45+0.9%N/A+106.0%$912.59M$58.97M-234.2190News CoverageEarnings ReportAnalyst DowngradeGap DownALNTAllient2.8527 of 5 stars$43.29-1.2%$35.00-19.1%+152.4%$733.77M$529.97M50.342,525Analyst ForecastTRNSTranscat3.5877 of 5 stars$72.73-1.3%$112.20+54.3%-40.6%$677.84M$278.42M50.861,245News CoverageAnalyst UpgradeLABStandard BioTools2.4744 of 5 stars$1.27-2.3%$1.55+22.0%-26.7%$485.13M$174.43M-3.97620News CoveragePositive NewsAnalyst ForecastCTKBCytek Biosciences2.3717 of 5 stars$3.38-0.6%$5.60+65.7%-22.6%$430.00M$200.45M-67.60500News CoverageAnalyst UpgradeSENSSenseonics2.2829 of 5 stars$0.44-3.8%$1.54+247.5%+37.5%$360.50M$25.47M-3.4090News CoverageGap UpFEIMFrequency Electronics2.5634 of 5 stars$32.09+6.6%$43.00+34.0%+215.3%$312.88M$69.81M14.01200Positive NewsAnalyst ForecastMASS908 Devices1.8549 of 5 stars$8.15+1.7%$8.00-1.8%+162.9%$292.26M$59.63M-15.0960Analyst ForecastQTRXQuanterix1.7911 of 5 stars$5.25+1.2%$11.75+123.8%-47.6%$243.97M$137.42M-2.88460News CoverageAnalyst Forecast Related Companies and Tools Related Companies EYPT Competitors AEHR Competitors ALNT Competitors TRNS Competitors LAB Competitors CTKB Competitors SENS Competitors FEIM Competitors MASS Competitors QTRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QSI) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum-Si Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum-Si With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
